Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Pernicious Anemia Diagnosis And Treatment Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for the diagnosis and treatment of pernicious anemia has seen a robust expansion in the past few years. It is expected to increase from $1.42 billion in 2024 to $1.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.7%. This significant growth during the historic period can be credited to a rise in Vitamin B12 deficiency awareness, an increase in the occurrence of autoimmune disorders, a burgeoning geriatric population, amplified education of physicians on anemia, and the availability of oral and injectable Vitamin B12.
The market for the diagnosis and treatment of pernicious anemia is projected to exhibit robust growth in the upcoming years, with its size anticipated to reach $1.96 billion in 2029, growing at a CAGR of 6.7%. This growth during the projected period can be linked to factors such as the proliferation of telemedicine services, an increasing demand for advanced diagnosis, a heightened emphasis on individualized medicine, governmental testing initiatives, and a rising patient inclination towards non-invasive therapies. Prime trends predicted for this forecast period encompass the advent of long-lasting vitamin B12 formulas, increased application of diagnostic kits suitable for home use, the utilization of AI for anemia identification, the surge of digital health tracking tools, and progress in diagnostic technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24360&type=smp
Which Primay Drivers Are Accelerating Growth in the Pernicious Anemia Diagnosis And Treatment Market?
The increasing occurrence of vitamin B12 deficiency is anticipated to fuel expansion in the pernicious anemia diagnosis and treatment market. A shortfall of vitamin B12 leads to insufficient production of red blood cells in the body, triggering symptoms like fatigue, weakness, and neurological issues. The upsurge in B12 deficiency can be traced back to the growing embracement of plant-based diets, which often do not have enough natural B12 sources and may result in inadequate intake without appropriate supplementation. This deficiency aids in the diagnosis and treatment of pernicious anemia, since low vitamin B12 directly hampers the creation of red blood cells, leading physicians to employ B12 supplementation as a fundamental and effective treatment method. For example, in February 2023, a report by the National Health Service (NHS), a UK government health organization, established that deficiencies in both vitamin B12 and folate are more common among the elderly, impacting about 1 in 10 individuals aged 75 or over and 1 in 20 of those aged 65 to 74. Thus, the escalating occurrence of vitamin B12 deficiency is propelling growth in the pernicious anemia diagnosis and treatment market.
Which Primary Segments of the Pernicious Anemia Diagnosis And Treatment Market Are Driving Growth and Industry Transformations?
The pernicious anemia diagnosis and treatmentmarket covered in this report is segmented –
1) By Type: Complete Blood Count Test; Vitamin B12 Deficiency test; Intrinsic Factor Deficiency Test
2) By Treatment: Vitamin B12 Injections; Vitamin B12 Pills; Spray
3) By Route Of Administration: Injection; Oral; Intranasal
4) By End-User: Hospitals; Clinics; Diagnostic Centres; Other End-users
Subsegments:
1) By Complete Blood Count (CBC) Test: Red Blood Cell Count; Hemoglobin Concentration; Hematocrit Levels; Mean Corpuscular Volume (MCV); White Blood Cell Count; Platelet Count
2) By Vitamin B12 Deficiency Test: Serum Vitamin B12 Test; Methylmalonic Acid (MMA) Test; Homocysteine Test; Holotranscobalamin (Active B12) Test
3) By Intrinsic Factor Deficiency Test: Intrinsic Factor Antibody Test; Parietal Cell Antibody Test; Schilling Test; Gastrin Level Test
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24360&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Pernicious Anemia Diagnosis And Treatment Market?# Market?
North America was the largest region in the pernicious anemia diagnosis and treatment market in 2024. The regions covered in the pernicious anemia diagnosis and treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Pernicious Anemia Diagnosis And Treatment Industry Dynamics?
Prominent businesses in the pernicious anemia diagnosis and treatment market are channeling their efforts to create innovative solutions, such as vitamin B12 maintenance therapy alternatives, to promote patient compliance and long-term management of the disease. Vitamin B12 maintenance therapy methods involve continual, routine supplementation via oral tablets, injections, or nasal sprays to maintain sufficient B12 levels and stop the recurrence of deficiency-associated symptoms. For example, Lupin Pharmaceuticals Inc., a pharmaceutical company based in India, unveiled a cyanocobalamin nasal spray, 500 mcg/spray, in February 2024. This non-invasive option for vitamin B12 supplementation provides an effective and convenient solution for patients with pernicious anemia who have difficulties with oral forms of vitamin B12. It aids in increasing B12 absorption and handling vitamin B12 deficiency, ultimately improving patient adherence and treatment results.
View the full report here:
What Parameters Are Used to Define the Pernicious Anemia Diagnosis And Treatment Market?
Pernicious anemia diagnosis and treatment refers to the process of identifying and managing a condition where the body cannot produce enough healthy red blood cells due to impaired absorption of vitamin B12, often linked to the absence of intrinsic factor. Diagnosis involves assessing clinical symptoms such as fatigue, weakness, and neurological disturbances. Treatment focuses on restoring vitamin B12 levels to promote normal red blood cell production, relieve symptoms, and prevent long-term health complications.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24360
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model